Company profile
Neumora Therapeutics, Inc. Insider Trading
NMRAEvery SEC Form 4 insider trading filing for Neumora Therapeutics, Inc. (NMRA) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001885522
- Filings
- 101
- Insiders
- 32
- Last filing
- 2026-08-21
Activity summary
No insider transactions in the last 30 days. The most recent was on August 21, 2026, when Daljit Singh Aurora bought 20,553 shares. 101 filings from 32 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Neumora Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $15.0M.
90 day insight
Over the last 90 days, Neumora Therapeutics, Inc. insiders bought $302K (37 transactions) and sold $702K (11 transactions).
- Most active insider: Daljit Singh Aurora with 44 transactions totaling $1.0M.
- Largest single sale: $103K by Daljit Singh Aurora on Aug 20, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | Daljit Singh Aurora | NMRA | Option Exercise | 20,553 | $0.72 | $15K |
| Aug 21, 2026 | Daljit Singh Aurora | NMRA | Sale | 20,553 | $1.59 | $33K |
| Aug 21, 2026 | Daljit Singh Aurora | NMRA | Option Exercise | 21,055 | $0.72 | $15K |
| Aug 21, 2026 | Daljit Singh Aurora | NMRA | Sale | 21,055 | $1.60 | $34K |
| Aug 21, 2026 | Daljit Singh Aurora | NMRA | Option Exercise | 20,553 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=NMRA" \
-H "X-Api-Key: $KEY"Institutional Ownership
Top 13F-HR holders of Neumora Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →